Home > Journals > Minerva Endocrinologica > Past Issues > Articles online first > Minerva Endocrinologica 2017 Nov 20



Publication history
Cite this article as


A Journal on Endocrine System Diseases

Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,383



Minerva Endocrinologica 2017 Nov 20

DOI: 10.23736/S0391-1977.17.02779-1


language: English

Irisin as a regulator of bone and glucose metabolism: a narrative review

Silvia I. BRIGANTI 1, Gianluigi GASPA 2, Gaia TABACCO 1, Anda M. NACIU 1, Roberto CESAREO 3, Silvia MANFRINI 1, Andrea PALERMO 1

1 Unit of Endocrinology and Diabetes, Department of Medicine, Campus Bio-Medico University of Rome, Rome, Italy; 2 Department of Food Science and Nutrition, Campus Bio-Medico University of Rome, Rome, Italy; 3 Thyroid and Osteometabolisc Disease Center, "S. M. Goretti" Hospital, Latina, Italy


In humans, irisin is produced mainly by skeletal muscle in response to physical activity. It has been demonstrated that irisin plays a pivotal role in inducing fat browning and regulating energy expenditure. New findings from various studies conducted in both animals and humans suggest that irisin can affect bone and glucose metabolism. In particular, irisin is able to increase bone cortical mass by stimulating the osteoblast pathways, and irisin levels are inversely correlated with the incidence of fragility fractures among postmenopausal women affected by osteoporosis. Most available evidence shows that irisin significantly influences glucose and energy homeostasis. Indeed, higher irisin concentrations are inversely correlated with type 2 diabetes. Unfortunately, contradictory findings exist concerning the role of irisin in humans, and most of the human studies that have analyzed interactions between bone health, glucose metabolism, and irisin have several limitations; therefore, their results must be interpreted with caution. The purpose of this narrative review is mainly to describe the effects of irisin on glucose and bone metabolism.

KEY WORDS: Irisin - Osteoporosis - Muscle - Miokine - Diabetes

top of page

Publication History

Article first published online: November 20, 2017
Manuscript accepted: November 15, 2017
Manuscript received: November 12, 2017

Cite this article as

Briganti SI, Gaspa G, Tabacco G, Naciu AM, Cesareo R, Manfrini S, et al. Irisin as a regulator of bone and glucose metabolism: a narrative review. Minerva Endocrinol 2017 Nov 20. DOI: 10.23736/S0391-1977.17.02779-1

Corresponding author e-mail